Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Astrazeneca ADR buy Gilbert

Start price
22.02.21 / 50%
Target price
Performance (%)
This prediction is currently active. With a performance of -3.42%, the BUY prediction by Gilbert is trending in the wrong direction. Dividends of €0.79 are taken into consideration when calculating the performance. This prediction currently runs until 2022-02-22. The prediction end date can be changed by Gilbert at any time. Gilbert has 50% into this prediction

According to Gilbert what are the pros and cons of Astrazeneca ADR for the foreseeable future?

Could be worthwhile Investment >10% per year
Medium risks for its business
Small cyclical dependencies

Comments by Gilbert for this prediction

In the thread Astrazeneca ADR diskutieren

Buy Astrazeneca ADR